Observational studyAnnals of African medicine2026
Beyond HIV: Prevalence and Interaction of Immunosuppressive Conditions in Patients with Tuberculosis.
Observational study in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) remains a significant global public health issue. In Tanzania, TB prevalence and incidence rose by 2.1% and 2.3%, respectively, from 2020 to 2021. Current public health strategies focus mainly on HIV/AIDS-related TB, often neglecting other immunosuppressive conditions. This study aimed to assess the prevalence of immunosuppressive conditions beyond HIV in TB patients and explore their interactions. MATERIALS AND
methodsA retrospective observational study was conducted among TB patients admitted to or attending the TB clinic at Mbeya Zonal Referral Hospital, Mbeya City, southwestern Tanzania, from January 1, 2021, to February 29, 2024. Data were collected through comprehensive medical history reviews. Immunosuppressive factors were assessed in confirmed TB cases, particularly those present before TB diagnosis. Statistical analyses were performed using STATA version 17, with significance set at P ≤ 0.05 and a 95% confidence interval.
resultsA total of 322 TB patients with a mean age of 48 ± 20.8 years (range 2-92) were included. Among them, 38.2% were diagnosed with HIV/AIDS, 20.2% had type 2 diabetes (T2D) mellitus, 5% were malnourished, 3.7% had a history of prolonged corticosteroid use (>6 weeks), and 3.1% had cancer or were undergoing chemotherapy before TB diagnosis. HIV infection was significantly associated with T2D (χ 2 = 50.17, P < 0.001), cancer (χ 2 = 6.25, P = 0.01), prolonged corticosteroid use (χ 2 = 3.82, P = 0.05), and malnutrition (χ 2 = 3.73, P = 0.05). A total of 74.2% of TB patients had one or more immunosuppressive conditions prior to TB diagnosis, with 36% having additional factors beyond HIV/AIDS.
conclusionsHIV/AIDS is still a major immunosuppressive factor associated with TB development. However, other immunosuppressive conditions also contribute significantly to TB risk. Public health strategies should address these factors alongside HIV/AIDS to reduce the TB burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.